Vemurafenib combined with chidamide promotes senescence of secondary acute myeloid leukemia cells
Objective To explore the effect of vemurafenib (VEM) combined with chidamide (CDM) on cellular senescence in secondary acute myeloid leukemia (sAML). Methods sAML cell lines SKM-1 and MOLM-13 were divided into control group (sAML cells), VEM group (sAML cells treated with VEM), CDM group (sAML cells...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Chinês |
| Publicat: |
Editorial Office of Journal of Army Medical University
2023-08-01
|
| Col·lecció: | 陆军军医大学学报 |
| Matèries: | |
| Accés en línia: | http://aammt.tmmu.edu.cn/html/202305030.htm |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|